Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Increased Notching of the Corpus Callosum in Fetal Alcohol Spectrum Disorder: A Callosal Misunderstanding?
Journal: AJNR. American journal of neuroradiology
Published: October 08, 2019
Morphological changes of the dorsal contour of the corpus callosum during the first two years of life.
Journal: Pediatric radiology
Published: August 26, 2019
Coronoid Process Hyperplasia : A Rare Disorder Masquerading as Temporomandibular Joint Disease.
Journal: Clinical neuroradiology
Published: June 21, 2018
Routine Pre-Treatment MRI for Breast Cancer in a Single-Payer Medical Center: Effects on Surgical Choices, Timing and Outcomes.
Journal: Journal of Cancer
Published: July 05, 2016
Interim analysis of a phase I/IIa trial assessing E39+GM-CSF, a folate binding protein vaccine, to prevent recurrence in ovarian and endometrial cancer patients.
Journal: Oncotarget
Published: July 01, 2016
Peptide-Based Cancer Vaccine Strategies and Clinical Results.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: April 15, 2016
A phase I/IIa clinical trial in stage IV melanoma of an autologous tumor-dendritic cell fusion (dendritoma) vaccine with low dose interleukin-2.
Journal: Cancer immunology, immunotherapy : CII
Published: October 13, 2015
Analysis of Clinical and Pathologic Factors of Pure, Flat Epithelial Atypia on Core Needle Biopsy to Aid in the Decision of Excision or Observation.
Journal: Journal of Cancer
Published: May 24, 2015
Novel dendritic cell-based vaccination in late stage melanoma.
Journal: Human vaccines & immunotherapeutics
Published: December 09, 2014
Final report of the phase I/II clinical trial of the E75 (nelipepimut-S) vaccine with booster inoculations to prevent disease recurrence in high-risk breast cancer patients.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: June 08, 2014
The HER2 peptide nelipepimut-S (E75) vaccine (NeuVax™) in breast cancer patients at risk for recurrence: correlation of immunologic data with clinical response.
Journal: Immunotherapy
Published: June 05, 2014
Last Updated: 09/26/2026